trending Market Intelligence /marketintelligence/en/news-insights/trending/_SslW3NIm4CrnzKEaX-Exg2 content esgSubNav
In This List

Ritter Pharmaceuticals falls out of Nasdaq compliance

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Ritter Pharmaceuticals falls out of Nasdaq compliance

Ritter Pharmaceuticals Inc. fell out of compliance with Nasdaq's $1 minimum bid price listing rule.

The Los Angeles-based developer of drugs to treat gastrointestinal diseases has until June 24, 2019, to regain compliance, with a possibility for extension.

The company plans to evaluate available options to address the deficiency and regain compliance with the rule, the company said in a filing.